Copyright Reports & Markets. All rights reserved.

Global Gene Delivery System Technology Drug Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gene Delivery System Technology Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Viral Gene Delivery System
    • 1.2.3 Non-viral Gene Delivery System
  • 1.3 Market by Application
    • 1.3.1 Global Gene Delivery System Technology Drug Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Neurological Diseases
    • 1.3.3 Cancer
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gene Delivery System Technology Drug Market Perspective (2016-2027)
  • 2.2 Gene Delivery System Technology Drug Growth Trends by Regions
    • 2.2.1 Gene Delivery System Technology Drug Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Gene Delivery System Technology Drug Historic Market Share by Regions (2016-2021)
    • 2.2.3 Gene Delivery System Technology Drug Forecasted Market Size by Regions (2022-2027)
  • 2.3 Gene Delivery System Technology Drug Industry Dynamic
    • 2.3.1 Gene Delivery System Technology Drug Market Trends
    • 2.3.2 Gene Delivery System Technology Drug Market Drivers
    • 2.3.3 Gene Delivery System Technology Drug Market Challenges
    • 2.3.4 Gene Delivery System Technology Drug Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gene Delivery System Technology Drug Players by Revenue
    • 3.1.1 Global Top Gene Delivery System Technology Drug Players by Revenue (2016-2021)
    • 3.1.2 Global Gene Delivery System Technology Drug Revenue Market Share by Players (2016-2021)
  • 3.2 Global Gene Delivery System Technology Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Gene Delivery System Technology Drug Revenue
  • 3.4 Global Gene Delivery System Technology Drug Market Concentration Ratio
    • 3.4.1 Global Gene Delivery System Technology Drug Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gene Delivery System Technology Drug Revenue in 2020
  • 3.5 Gene Delivery System Technology Drug Key Players Head office and Area Served
  • 3.6 Key Players Gene Delivery System Technology Drug Product Solution and Service
  • 3.7 Date of Enter into Gene Delivery System Technology Drug Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Delivery System Technology Drug Breakdown Data by Type

  • 4.1 Global Gene Delivery System Technology Drug Historic Market Size by Type (2016-2021)
  • 4.2 Global Gene Delivery System Technology Drug Forecasted Market Size by Type (2022-2027)

5 Gene Delivery System Technology Drug Breakdown Data by Application

  • 5.1 Global Gene Delivery System Technology Drug Historic Market Size by Application (2016-2021)
  • 5.2 Global Gene Delivery System Technology Drug Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Gene Delivery System Technology Drug Market Size (2016-2027)
  • 6.2 North America Gene Delivery System Technology Drug Market Size by Type
    • 6.2.1 North America Gene Delivery System Technology Drug Market Size by Type (2016-2021)
    • 6.2.2 North America Gene Delivery System Technology Drug Market Size by Type (2022-2027)
    • 6.2.3 North America Gene Delivery System Technology Drug Market Size by Type (2016-2027)
  • 6.3 North America Gene Delivery System Technology Drug Market Size by Application
    • 6.3.1 North America Gene Delivery System Technology Drug Market Size by Application (2016-2021)
    • 6.3.2 North America Gene Delivery System Technology Drug Market Size by Application (2022-2027)
    • 6.3.3 North America Gene Delivery System Technology Drug Market Size by Application (2016-2027)
  • 6.4 North America Gene Delivery System Technology Drug Market Size by Country
    • 6.4.1 North America Gene Delivery System Technology Drug Market Size by Country (2016-2021)
    • 6.4.2 North America Gene Delivery System Technology Drug Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Gene Delivery System Technology Drug Market Size (2016-2027)
  • 7.2 Europe Gene Delivery System Technology Drug Market Size by Type
    • 7.2.1 Europe Gene Delivery System Technology Drug Market Size by Type (2016-2021)
    • 7.2.2 Europe Gene Delivery System Technology Drug Market Size by Type (2022-2027)
    • 7.2.3 Europe Gene Delivery System Technology Drug Market Size by Type (2016-2027)
  • 7.3 Europe Gene Delivery System Technology Drug Market Size by Application
    • 7.3.1 Europe Gene Delivery System Technology Drug Market Size by Application (2016-2021)
    • 7.3.2 Europe Gene Delivery System Technology Drug Market Size by Application (2022-2027)
    • 7.3.3 Europe Gene Delivery System Technology Drug Market Size by Application (2016-2027)
  • 7.4 Europe Gene Delivery System Technology Drug Market Size by Country
    • 7.4.1 Europe Gene Delivery System Technology Drug Market Size by Country (2016-2021)
    • 7.4.2 Europe Gene Delivery System Technology Drug Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Gene Delivery System Technology Drug Market Size (2016-2027)
  • 8.2 Asia-Pacific Gene Delivery System Technology Drug Market Size by Type
    • 8.2.1 Asia-Pacific Gene Delivery System Technology Drug Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Gene Delivery System Technology Drug Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Gene Delivery System Technology Drug Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Gene Delivery System Technology Drug Market Size by Application
    • 8.3.1 Asia-Pacific Gene Delivery System Technology Drug Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Gene Delivery System Technology Drug Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Gene Delivery System Technology Drug Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Gene Delivery System Technology Drug Market Size by Region
    • 8.4.1 Asia-Pacific Gene Delivery System Technology Drug Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Gene Delivery System Technology Drug Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Gene Delivery System Technology Drug Market Size (2016-2027)
  • 9.2 Latin America Gene Delivery System Technology Drug Market Size by Type
    • 9.2.1 Latin America Gene Delivery System Technology Drug Market Size by Type (2016-2021)
    • 9.2.2 Latin America Gene Delivery System Technology Drug Market Size by Type (2022-2027)
    • 9.2.3 Latin America Gene Delivery System Technology Drug Market Size by Type (2016-2027)
  • 9.3 Latin America Gene Delivery System Technology Drug Market Size by Application
    • 9.3.1 Latin America Gene Delivery System Technology Drug Market Size by Application (2016-2021)
    • 9.3.2 Latin America Gene Delivery System Technology Drug Market Size by Application (2022-2027)
    • 9.3.3 Latin America Gene Delivery System Technology Drug Market Size by Application (2016-2027)
  • 9.4 Latin America Gene Delivery System Technology Drug Market Size by Country
    • 9.4.1 Latin America Gene Delivery System Technology Drug Market Size by Country (2016-2021)
    • 9.4.2 Latin America Gene Delivery System Technology Drug Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gene Delivery System Technology Drug Market Size (2016-2027)
  • 10.2 Middle East & Africa Gene Delivery System Technology Drug Market Size by Type
    • 10.2.1 Middle East & Africa Gene Delivery System Technology Drug Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Gene Delivery System Technology Drug Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Gene Delivery System Technology Drug Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Gene Delivery System Technology Drug Market Size by Application
    • 10.3.1 Middle East & Africa Gene Delivery System Technology Drug Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Gene Delivery System Technology Drug Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Gene Delivery System Technology Drug Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Gene Delivery System Technology Drug Market Size by Country
    • 10.4.1 Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Gene Delivery System Technology Drug Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Biogen
    • 11.1.1 Biogen Company Details
    • 11.1.2 Biogen Business Overview
    • 11.1.3 Biogen Gene Delivery System Technology Drug Introduction
    • 11.1.4 Biogen Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.1.5 Biogen Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Gene Delivery System Technology Drug Introduction
    • 11.2.4 Novartis Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.2.5 Novartis Recent Development
  • 11.3 Gilead Sciences
    • 11.3.1 Gilead Sciences Company Details
    • 11.3.2 Gilead Sciences Business Overview
    • 11.3.3 Gilead Sciences Gene Delivery System Technology Drug Introduction
    • 11.3.4 Gilead Sciences Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.3.5 Gilead Sciences Recent Development
  • 11.4 Sarepta Therapeutics
    • 11.4.1 Sarepta Therapeutics Company Details
    • 11.4.2 Sarepta Therapeutics Business Overview
    • 11.4.3 Sarepta Therapeutics Gene Delivery System Technology Drug Introduction
    • 11.4.4 Sarepta Therapeutics Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.4.5 Sarepta Therapeutics Recent Development
  • 11.5 Alnylam Pharmaceuticals
    • 11.5.1 Alnylam Pharmaceuticals Company Details
    • 11.5.2 Alnylam Pharmaceuticals Business Overview
    • 11.5.3 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Introduction
    • 11.5.4 Alnylam Pharmaceuticals Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.5.5 Alnylam Pharmaceuticals Recent Development
  • 11.6 Amgen
    • 11.6.1 Amgen Company Details
    • 11.6.2 Amgen Business Overview
    • 11.6.3 Amgen Gene Delivery System Technology Drug Introduction
    • 11.6.4 Amgen Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.6.5 Amgen Recent Development
  • 11.7 Spark Therapeutics
    • 11.7.1 Spark Therapeutics Company Details
    • 11.7.2 Spark Therapeutics Business Overview
    • 11.7.3 Spark Therapeutics Gene Delivery System Technology Drug Introduction
    • 11.7.4 Spark Therapeutics Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.7.5 Spark Therapeutics Recent Development
  • 11.8 Akcea Therapeutics
    • 11.8.1 Akcea Therapeutics Company Details
    • 11.8.2 Akcea Therapeutics Business Overview
    • 11.8.3 Akcea Therapeutics Gene Delivery System Technology Drug Introduction
    • 11.8.4 Akcea Therapeutics Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.8.5 Akcea Therapeutics Recent Development
  • 11.9 bluebird bio
    • 11.9.1 bluebird bio Company Details
    • 11.9.2 bluebird bio Business Overview
    • 11.9.3 bluebird bio Gene Delivery System Technology Drug Introduction
    • 11.9.4 bluebird bio Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.9.5 bluebird bio Recent Development
  • 11.10 Sunway Biotech
    • 11.10.1 Sunway Biotech Company Details
    • 11.10.2 Sunway Biotech Business Overview
    • 11.10.3 Sunway Biotech Gene Delivery System Technology Drug Introduction
    • 11.10.4 Sunway Biotech Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.10.5 Sunway Biotech Recent Development
  • 11.11 SIBIONO
    • 11.11.1 SIBIONO Company Details
    • 11.11.2 SIBIONO Business Overview
    • 11.11.3 SIBIONO Gene Delivery System Technology Drug Introduction
    • 11.11.4 SIBIONO Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.11.5 SIBIONO Recent Development
  • 11.12 AnGes
    • 11.12.1 AnGes Company Details
    • 11.12.2 AnGes Business Overview
    • 11.12.3 AnGes Gene Delivery System Technology Drug Introduction
    • 11.12.4 AnGes Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.12.5 AnGes Recent Development
  • 11.13 Orchard Therapeutics
    • 11.13.1 Orchard Therapeutics Company Details
    • 11.13.2 Orchard Therapeutics Business Overview
    • 11.13.3 Orchard Therapeutics Gene Delivery System Technology Drug Introduction
    • 11.13.4 Orchard Therapeutics Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.13.5 Orchard Therapeutics Recent Development
  • 11.14 Human Stem Cells Institute
    • 11.14.1 Human Stem Cells Institute Company Details
    • 11.14.2 Human Stem Cells Institute Business Overview
    • 11.14.3 Human Stem Cells Institute Gene Delivery System Technology Drug Introduction
    • 11.14.4 Human Stem Cells Institute Revenue in Gene Delivery System Technology Drug Business (2016-2021)
    • 11.14.5 Human Stem Cells Institute Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Gene Delivery System Technology Drug Scope and Market Size
    Gene Delivery System Technology Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gene Delivery System Technology Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Viral Gene Delivery System
    Non-viral Gene Delivery System

    Segment by Application
    Neurological Diseases
    Cancer
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute

    Buy now